What Is CJC 1295 No DAC Used For?

CJC-1295 no DAC is a synthetic growth hormone-releasing hormone (GHRH) analog that researchers and bodybuilding communities study for its ability to raise growth hormone (GH) and IGF-1 levels. Because it lacks the Drug Affinity Complex (DAC), it clears the body far faster than CJC-1295 with DAC. It is not FDA-approved for human use in the United States and is legally sold only as a research chemical.

What Is CJC-1295 No DAC?

CJC-1295 no DAC is also known as Mod GRF(1-29) or modified GRF 1-29. It is a shortened, chemically modified version of natural GHRH, and four amino acid substitutions make it more resistant to enzymatic breakdown than the native hormone.

Another way people phrase the question is what is cjc-1295 without dac, and the answer is the same: it is the short-acting form of the same peptide family. You will usually find it sold as a lyophilized powder that must be reconstituted with bacteriostatic water before use.

A few basics are worth keeping straight:

• Peptide class: GHRH analog
• Common names: Mod GRF(1-29), CJC-1295 without DAC
• Estimated half-life: roughly 30 minutes
• Route studied: subcutaneous injection
• Regulatory status: not FDA-approved for human use

How It Works in the Body

To understand what does cjc 1295 no dac do at the biological level, start with the pituitary gland. The peptide binds to GHRH receptors there and signals the pituitary to release growth hormone in pulses.

Because there is no DAC, the peptide does not bind covalently to albumin in the bloodstream. That means it produces shorter, sharper GH pulses that more closely mimic the body's natural rhythm instead of a long, flat elevation.

Growth hormone then travels to the liver and other tissues, where it drives IGF-1 production. Researchers typically measure both GH and IGF-1 when they study the compound.

What CJC-1295 No DAC Is Used For

Most interest in this peptide falls into a handful of categories. None of them are supported by large randomized trials of the no-DAC version specifically, so the claims deserve caution.

• Growth hormone research: studying pulsatile GH release and the downstream IGF-1 response.
• Body composition research: exploring whether increased GH signaling shifts lean mass and fat mass.
• Recovery and tissue repair: anecdotal reports about joints, tendons, and skin that remain largely unverified.
• Anti-aging and wellness clinics: off-label use in some countries, often alongside other peptides.
• Athletic performance: used illicitly by some athletes; banned by WADA and most sports organizations.

One important caveat: the well-known 2006 human study that showed a large, sustained rise in GH and IGF-1 used CJC-1295 with DAC, not the no-DAC version. Extrapolating those results directly to Mod GRF(1-29) is common online but not scientifically clean.

CJC-1295 DAC vs No DAC

The DAC group changes almost everything about how the peptide behaves in the body. Here is a side-by-side comparison of the two forms.

Feature	CJC-1295 with DAC	CJC-1295 no DAC
Half-life	About 6-8 days	About 30 minutes
Albumin binding	Yes (covalent)	No
Typical research schedule	Once weekly	2-3 times daily
GH release pattern	Continuous elevation	Pulsatile, closer to natural
IGF-1 impact	Larger and longer-lasting	Smaller and shorter
Reported side effects	More pronounced	Generally milder

The debate over cjc-1295 dac vs no dac which is better usually comes down to goals. Researchers who want a natural pulse pattern tend to prefer the no-DAC version, while those who want fewer injections and steadier levels lean toward the DAC version.

Stacking CJC-1295 No DAC With Ipamorelin

People searching what is cjc 1295 ipamorelin used for are almost always looking at this combination. CJC-1295 no DAC acts on the GHRH receptor, while ipamorelin acts on the ghrelin receptor, so the two work through separate pathways that reinforce each other.

Option	Mechanism	Reported GH response	Common research schedule
CJC-1295 no DAC alone	GHRH receptor agonist	Moderate, pulsatile	2-3 injections daily
Ipamorelin alone	Ghrelin receptor agonist	Moderate, pulsatile	2-3 injections daily
Both together	Two complementary pathways	Synergistic in early research	1-3 injections daily

Ipamorelin is often described as the more selective of the ghrelin mimetics, meaning it triggers less cortisol and prolactin release than older secretagogues such as GHRP-6. That selectivity is a big reason the pairing shows up so often in forum discussions and clinic protocols.

Side Effects, Safety, and Legal Status

Reported side effects of CJC-1295 no DAC include injection site irritation, flushing, headache, dizziness, fatigue, and water retention. Some users also notice increased appetite, especially when it is stacked with ipamorelin.

More serious concerns include possible effects on blood glucose, cortisol, and prolactin, particularly at high or frequent doses. Long-term safety data in healthy adults does not exist for this specific peptide.

In the United States, CJC-1295 is not approved by the FDA for human use. It is sold as a research chemical, and products labeled for research use only are not held to the same purity standards as prescription drugs.

The compound is also banned by the World Anti-Doping Agency and most athletic governing bodies. Anyone considering it should talk with a licensed healthcare professional instead of relying on forum advice.

Bottom Line

CJC-1295 no DAC is a short-acting GHRH analog studied for its ability to stimulate pulsatile growth hormone release.

It is most often compared with CJC-1295 with DAC and most often paired in research with ipamorelin.

CJC-1295 no DAC is not FDA-approved for human use in the United States.

Human safety data for the no-DAC form is limited, and quality control in the research-chemical market varies widely.

COMMON QUESTIONS

Frequently Asked Questions

Is CJC-1295 no DAC the same as Mod GRF 1-29?

Yes. Mod GRF(1-29) and modified GRF 1-29 are common alternate names for CJC-1295 without DAC. All of them describe the same 29-amino-acid GHRH analog that lacks the Drug Affinity Complex.

How long does CJC-1295 no DAC stay active in the body?

The estimated half-life is around 30 minutes, which is why it is typically studied with multiple daily injections rather than once-weekly dosing. CJC-1295 with DAC, by contrast, has a half-life of roughly 6 to 8 days because it binds to albumin.

Is CJC-1295 no DAC legal in the United States?

CJC-1295 is not FDA-approved for human use in the United States. It is sold as a research chemical for laboratory purposes only, and it is banned by WADA and most sports organizations.